Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2009, Article ID 436515, 6 pages
http://dx.doi.org/10.1155/2009/436515
Clinical Study

Chemokine Receptor-5 32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation

1Department of General, Visceral and Transplantation Surgery, Charité-University Medicine of Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
2Department of General and Visceral Surgery, J.W. Goethe University Frankfurt/Main, Theodor Stern Kai 7, 60590 Frankfurt/Main, Germany
3Department of Transplantation Surgery, Johannes Gutenberg University of Mainz, Langenbeckstraße 1, 55131 Mainz, Germany

Received 20 November 2008; Accepted 23 February 2009

Academic Editor: Carlos Esquivel

Copyright © 2009 Christoph Heidenhain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. J. Guichelaar, J. T. Benson, M. Malinchoc, R. A. F. Kroma, R. H. Wiesner, and M. R. Charlton, “Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation,” American Journal of Transplantation, vol. 3, no. 7, pp. 885–890, 2003. View at Publisher · View at Google Scholar
  2. L. Sanchez-Urdazpal, G. J. Gores, E. M. Ward et al., “Ischemic-type biliary complications after orthotopic liver transplantation,” Hepatology, vol. 16, no. 1, pp. 49–53, 1992. View at Publisher · View at Google Scholar
  3. J. M. Langrehr, A. Schneller, R. Neuhaus, T. Vogl, R. Hintze, and P. Neuhaus, “Etiologic factors and incidence of ischemic type biliary lesions (ITBL) after liver transplantation,” Langenbecks Archiv für Chirurgie, vol. 115, pp. 1560–1562, 1998. View at Google Scholar
  4. S. Li, R. J. Stratta, A. N. Langnas et al., “Diffuse biliary tract injury after orthotopic liver transplantation,” American Journal of Surgery, vol. 164, no. 5, pp. 536–540, 1992. View at Google Scholar
  5. N. Nakamura, S. Nishida, G. R. Neff et al., “Intrahepatic biliary strictures without hepatic artery thrombosis after liver transplantation: an analysis of 1,113 liver transplantations at a single center,” Transplantation, vol. 79, no. 4, pp. 427–432, 2005. View at Publisher · View at Google Scholar
  6. C. Moench, A. Uhrig, A. W. Lohse, and G. Otto, “CC chemokine receptor 5Δ32 polymorphism—a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation,” Liver Transplantation, vol. 10, no. 3, pp. 434–439, 2004. View at Publisher · View at Google Scholar
  7. L. Sanchez-Urdazpal, G. J. Gores, E. M. Ward et al., “Clinical outcome of ischemic-type biliary complications after liver transplantation,” Transplantation Proceedings, vol. 25, no. 1, part 2, pp. 1107–1109, 1993. View at Google Scholar
  8. L. Sanchez-Urdazpal, G. J. Gores, E. M. Ward et al., “Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation,” Hepatology, vol. 17, no. 4, pp. 605–609, 1993. View at Publisher · View at Google Scholar
  9. L. Fischer-Maas, R. Schneppenheim, F. Oyen et al., “Analysis of the CC chemokine receptor 5?32 polymorphism in pediatric liver transplant recipients,” Pediatric Transplantation, vol. 12, no. 7, pp. 769–772, 2008. View at Google Scholar
  10. P. C. Sabeti, E. Walsh, S. F. Schaffner et al., “The case for selection at CCR5-?32,” PLoS Biology, vol. 3, no. 11, p. e378, 2005. View at Publisher · View at Google Scholar
  11. L. Wu, W. A. Paxton, N. Kassam et al., “CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro,” Journal of Experimental Medicine, vol. 185, no. 9, pp. 1681–1691, 1997. View at Publisher · View at Google Scholar
  12. M. Fischereder, B. Luckow, B. Hocher et al., “CC chemokine receptor 5 and renal-transplant survival,” The Lancet, vol. 357, no. 9270, pp. 1758–1761, 2001. View at Publisher · View at Google Scholar
  13. J. A. Belperio, M. D. Burdick, M. P. Keane et al., “The role of the CC chemokine, RANTES, in acute lung allograft rejection,” The Journal of Immunology, vol. 165, no. 1, pp. 461–472, 2000. View at Google Scholar
  14. J. E. Fildes, A. H. Walker, R. Howlett et al., “Donor CCR5 ?32 polymorphism and outcome following cardiac transplantation,” Transplantation Proceedings, vol. 37, no. 5, pp. 2247–2249, 2005. View at Publisher · View at Google Scholar
  15. R. Abdi, R. N. Smith, L. Makhlouf et al., “The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection,” Diabetes, vol. 51, no. 8, pp. 2489–2495, 2002. View at Publisher · View at Google Scholar
  16. J. J. Martinson, N. H. Chapman, D. C. Rees, Y.-T. Liu, and J. B. Clegg, “Global distribution of the CCR5 gene 32-basepair deletion,” Nature Genetics, vol. 16, no. 1, pp. 100–103, 1997. View at Publisher · View at Google Scholar
  17. P. Garred, H. O. Madsen, J. Petersen et al., “CC chemokine receptor 5 polymorphism in rheumatoid arthritis,” Journal of Rheumatology, vol. 25, no. 8, pp. 1462–1465, 1998. View at Google Scholar
  18. V. Pokorny, F. McQueen, S. Yeoman et al., “Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 64, no. 3, pp. 487–490, 2005. View at Publisher · View at Google Scholar
  19. K. Pulkkinen, M. Luomala, H. Kuusisto et al., “Increase in CCR5 ?32/?32 genotype in multiple sclerosis,” Acta Neurologica Scandinavica, vol. 109, no. 5, pp. 342–347, 2004. View at Publisher · View at Google Scholar
  20. O. H. Kantarci, Y. Morales, P. A. Ziemer et al., “CCR5?32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis,” Journal of Neuroimmunology, vol. 169, no. 1-2, pp. 137–143, 2005. View at Publisher · View at Google Scholar
  21. D. E. J. Jones and P. T. Donaldson, “Genetic factors in the pathogenesis of primary biliary cirrhosis,” Clinics in Liver Disease, vol. 7, no. 4, pp. 841–864, 2003. View at Publisher · View at Google Scholar
  22. R. Eri, J. R. Jonsson, N. Pandeya et al., “CCR5-?32 mutation is strongly associated with primary sclerosing cholangitis,” Genes and Immunity, vol. 5, no. 6, pp. 444–450, 2004. View at Publisher · View at Google Scholar
  23. R. F. Liermann Garcia, C. Evangelista Garcia, P. McMaster, and J. Neuberger, “Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center,” Hepatology, vol. 33, no. 1, pp. 22–27, 2001. View at Publisher · View at Google Scholar
  24. R. B. Feller, R. C. Waugh, W. S. Selby, P. M. Dolan, A. G. R. Sheil, and G. W. Mccaughan, “Biliary strictures after liver transplantation: clinical picture, correlates and outcomes,” Journal of Gastroenterology and Hepatology, vol. 11, no. 1, pp. 21–25, 1996. View at Publisher · View at Google Scholar
  25. S. Narumi, J. P. Roberts, J. C. Emond, J. Lake, and N. L. Ascher, “Liver transplantation for sclerosing cholangitis,” Hepatology, vol. 22, no. 2, pp. 451–457, 1995. View at Publisher · View at Google Scholar
  26. R. Sheng, W. L. Campbell, A. B. Zajko, and R. L. Baron, “Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease,” American Journal of Roentgenology, vol. 166, no. 5, pp. 1109–1113, 1996. View at Google Scholar
  27. I. W. Graziadei, R. H. Wiesner, K. P. Batts et al., “Recurrence of primary sclerosing cholangitis following liver transplantation,” Hepatology, vol. 29, no. 4, pp. 1050–1056, 1999. View at Publisher · View at Google Scholar
  28. D. R. Jeyarajah, G. J. Netto, S. P. Lee et al., “Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?” Transplantation, vol. 66, no. 10, pp. 1300–1306, 1998. View at Publisher · View at Google Scholar
  29. Z. Ben-Ari, O. Pappo, and E. Mor, “Intrahepatic cholestasis after liver transplantation,” Liver Transplantation, vol. 9, no. 10, pp. 1005–1018, 2003. View at Publisher · View at Google Scholar